Refine Search
(18)
(29)
(61)
(64)

Parkinson's Disease - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2018’, provides an overview of the Parkinson's Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for...

Multiple Sclerosis - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2018’, provides an overview of the Multiple Sclerosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Multiple...

Alzheimer's Disease - Pipeline Review, H1 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2019’, provides an overview of the Alzheimer's Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2016’, provides an overview of the Secondary Progressive Multiple Sclerosis (SPMS) pipeline landscape.

The report provides comprehensive info...

Status Epilepticus - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Status Epilepticus - Pipeline Review, H2 2016’, provides an overview of the Status Epilepticus pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Status E...

Nerve Injury - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Nerve Injury - Pipeline Review, H2 2016’, provides an overview of the Nerve Injury pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Nerve Injury, comple...

Seizures - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Seizures - Pipeline Review, H2 2016’, provides an overview of the Seizures pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Seizures, complete with anal...

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2016’, provides an overview of the Peripheral Neuropathy (Sensory Neuropathy) pipeline landscape.

The report provides comprehensive information on...

Diabetic Neuropathic Pain - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Neuropathic Pain - Pipeline Review, H2 2016’, provides an overview of the Diabetic Neuropathic Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Acute Pain - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acute Pain - Pipeline Review, H2 2016’, provides an overview of the Acute Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Acute Pain, complete wit...

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2016’, provides an overview of the Primary Progressive Multiple Sclerosis (PPMS) pipeline landscape.

The report provides comprehensive informat...

Ocular Pain - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ocular Pain - Pipeline Review, H2 2016’, provides an overview of the Ocular Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ocular Pain, complete ...

Anxiety Disorders - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H2 2016’, provides an overview of the Anxiety Disorders pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Anxiety Di...

Cognitive Impairment - Pipeline Review, H2 2016

  • $2,000
  • September 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H2 2016’, provides an overview of the Cognitive Impairment pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cogn...

Postherpetic Neuralgia - Pipeline Review, H2 2016

  • $2,000
  • September 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Postherpetic Neuralgia - Pipeline Review, H2 2016’, provides an overview of the Postherpetic Neuralgia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...